Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,586 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impaired Cellular and Antibody immunity after COVID-19 in Chronically Immunosuppressed Transplant Recipients.
Ashokkumar C, Rohan V, Kroemer AH, Rao S, Mazariegos G, Higgs BW, Nadig S, Almeda J, Dhani H, Khan K, Yazigi N, Ekong U, Kaufman S, Betancourt-Garcia MM, Mukund K, Sethi P, Mehrotra S, Soltys K, Singh MS, Bond G, Khanna A, Ningappa M, Spishock B, Sindhi E, Atale N, Saunders M, Baliga P, Fishbein T, Subramaniam S, Sindhi R. Ashokkumar C, et al. Among authors: kaufman s. J Surg Res (Houst). 2023;6(4):348-363. doi: 10.26502/jsr.10020321. Epub 2023 Oct 18. J Surg Res (Houst). 2023. PMID: 38606317 Free PMC article.
Impaired T-cell and antibody immunity after COVID-19 infection in chronically immunosuppressed transplant recipients.
Ashokkumar C, Rohan V, Kroemer AH, Rao S, Mazariegos G, Higgs BW, Nadig S, Almeda J, Dhani H, Khan K, Yazigi N, Ekong U, Kaufman S, Betancourt-Garcia MM, Mukund K, Sethi P, Mehrotra S, Soltys K, Singh MS, Bond G, Khanna A, Ningappa M, Spishock B, Sindhi E, Atale N, Saunders M, Baliga P, Fishbein T, Subramaniam S, Sindhi R. Ashokkumar C, et al. Among authors: kaufman s. bioRxiv [Preprint]. 2021 May 4:2021.05.03.442371. doi: 10.1101/2021.05.03.442371. bioRxiv. 2021. PMID: 33972936 Free PMC article. Updated. Preprint.
Suppressor T helper type 17 cell responses in intestinal transplant recipients with allograft rejection.
Belyayev L, Kang J, Sadat M, Loh K, Patil D, Muralidaran V, Khan K, Kaufman S, Subramanian S, Gusev Y, Bhuvaneshwar K, Ressom H, Varghese R, Ekong U, Matsumoto CS, Robson SC, Fishbein TM, Kroemer A. Belyayev L, et al. Among authors: kaufman s. Hum Immunol. 2024 May;85(3):110773. doi: 10.1016/j.humimm.2024.110773. Epub 2024 Mar 16. Hum Immunol. 2024. PMID: 38494386
Evaluation of pediatric patients for intestinal transplantation in the modern era.
Bryan NS, Russell SC, Ozler O, Sugiguchi F, Yazigi NA, Khan KM, Ekong UD, Vitola BE, Guerra JF, Kroemer A, Fishbein TM, Matsumoto CS, Ghobrial SS, Kaufman SS. Bryan NS, et al. Among authors: kaufman ss. J Pediatr Gastroenterol Nutr. 2024 Jun 3. doi: 10.1002/jpn3.12274. Online ahead of print. J Pediatr Gastroenterol Nutr. 2024. PMID: 38828781
Discovery of Potent, Selective, and Orally Available IRE1α Inhibitors Demonstrating Comparable PD Modulation to IRE1 Knockdown in a Multiple Myeloma Model.
Braun MG, Ashkenazi A, Beveridge RE, Castanedo G, Wallweber HA, Beresini MH, Clark KR, De Bruyn T, Fu L, Gibbons P, Jiang F, Kaufman S, Kan D, Kiefer JR, Leclerc JP, Lemire A, Ly C, Segal E, Sims J, Wang W, Wei W, Zhao L, Schwarz JB, Rudolph J. Braun MG, et al. Among authors: kaufman s. J Med Chem. 2024 May 15. doi: 10.1021/acs.jmedchem.3c02425. Online ahead of print. J Med Chem. 2024. PMID: 38748820
The 340B Program and oral specialty drugs for advanced prostate cancer.
Faraj KS, Kaufman SR, Oerline M, Herrel LA, Maganty A, Caram MEV, Shahinian VB, Hollenbeck BK. Faraj KS, et al. Among authors: kaufman sr. Cancer. 2024 Jun 15;130(12):2160-2168. doi: 10.1002/cncr.35262. Epub 2024 Feb 23. Cancer. 2024. PMID: 38395607
1,586 results